期刊文献+

改良保护液在室间隔缺损合并动脉导管未闭的应用

Improved cardioplegia preservation solution in ventricular septal defect with patent ductus arteriosus in the heart of myocardial protection during open heart surgery for the clinical observation
暂未订购
导出
摘要 目的:回顾性分析改良心肌保护液在59例室间隔缺损(VSD)合并动脉导管未闭(PDA)外科治疗的临床资料,探讨其外科治疗经验.方法:研制的改良心肌保护液是在全面细致分析UW液、HTK液配方的基础上,加以改良,并应用腺苷和中药丹参,即集中UW液、HTK液及祖国医学的优点,采用体外循环心脏停跳下行动脉导管结扎或缝合术以及VSD修补术,其中男21例,女38例,年龄2个月~38岁;直接分离结扎导管19例;其余病例经肺动脉切口缝合;其中利用补片修补动脉导管3例.结果:全组无死亡,随访3个月~7年,复查心脏超声均未发现VSD残余分流,无远期死亡病例.结论:改良的保护液与ST.Thomas液对心肌有良好的保护效果.VSD合并动脉导管未闭一旦明确诊断,应该早期手术治疗,以避免肺动脉高压的发生,手术中探查和进行肺动脉压力,主动脉压力比值测定有助于手术方式的选择和制定围手术期处理方案,心脏不停跳技术可作为安全有效的方法应用于VSD合并PDA的外科治疗. Objective:A retrospective analysis of clinical data of improved-cardioplegia in 59 patients with ventricular septal defect (VSD) combined with patent ductus arteriosus (PDA) treatment, and to explore the surgical treatment. Methods: improved myocardial preservation solution is a comprehensive and detailed analysis of UW solution, HTK solution based on the formula, to be improved, and adenosine and Chinese medicine Danshen, the concentration of UW solution, HTK solution and the advantages of Chinese medicine, in vitro Circulating cardiac arrest downstream arterial ligation or suturing, and VSD repair, including 21 males and 38 females, aged 2 months of a 38-year-old; direct separation duct ligation in 19 cases; the remaining cases were pulmonary artery incision; which use up Patch in 3 cases of patent ductus arteriosus. Results: No deaths, followed up 3 months to 7 years, the review found no cardiac ul- trasound residual VSD shunt. No long-term mortality. Conclusions: The improved protection of fluid and ST.Thomas a good solution on myocardial protection effect. VSD combined with patent ductus arteriosus, once diagnosed, surgical treat ment should be early to avoid the occurrence of pulmonary hypertension, surgical exploration and for pulmonary arterial pressure, aortic pressure ratio determination of choice of surgical approach and contribute to development ofperioperative.
出处 《安徽卫生职业技术学院学报》 2013年第3期18-19,共2页 Journal of Anhui Health Vocational & Technical College
基金 安徽省卫生厅科研计划课题(项目编号:09A006)
关键词 改良心肌保护液 室间隔缺损 动脉导管未闭 体外循环 心脏外科手术 Improved myocardial preservation solution:Ventricular septal defect Patent ductus arteriosus Cardiac surgery Cardiac surgical procedures
  • 相关文献

参考文献2

二级参考文献15

  • 1饶金霞.糖尿病骨质疏松的预防[J].国际护理学杂志,2006,25(7):515-516. 被引量:2
  • 2Magann EF,Chauhan SP,Doherty DA. A review of idiopathic hydramnios and pregnancy outcomes[J].Obstetrical and Gynecological Survey,2007,(12):795-802.
  • 3Wang S,Amidi F,Beall M. Aquaporin 3 expression in human fetal membranes and its up-regulation by cyclic adenosine monophosphate in amnion epithelial cell culture[J].Journal of the Society For Gynecologic Investigation,2006,(03):181-185.
  • 4Zhu XQ,Jiang SS,Zhu XJ. Expression of aquaporin 1 and aquaporin 3 in fetal membranes and placenta in human term pregnancies with oligohydramnios[J].Placenta,2009,(08):670-676.doi:10.1016/j.placenta.2009.05.010.
  • 5Chu HN,Shen MJ. Treating oligohydramnios with extract of Salvia miltiorrhiza:a randomized control trial[J].Ther Clin Risk Manag,2008,(01):287-290.
  • 6Kang DG,Oh H,Sohn EJ. Lithospermic acid B isolated from Salvia miltiorrhiza ameliorates ischemia/reperfusion-induced renal injury in rats[J].Life Sciences,2004,(15):1801-1816.
  • 7乐杰.妇产科学[M]北京:人民卫生出版社,2008128-129.
  • 8Zhou L,Zuo Z,Chow MS. Danshen:an overview of its chemistry,pharmacology,pharmacokinetics,and clinical use[J].Journal of Clinical Pharmacology,2005,(12):1345-1359.
  • 9Wang L,Zhou GB,Liu P. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia[J].Proceedings of the National Academy of Sciences(USA),2008,(12):4826-4831.
  • 10张晓燕,崔燎,吴铁.丹参素防治去卵巢大鼠牙槽骨骨量的丢失[J].口腔医学研究,2008,24(2):148-151. 被引量:18

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部